Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis

PHASE3CompletedINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

March 9, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

September 27, 2017

Conditions
Cryptococcal MeningitisFungal Meningitis
Interventions
DRUG

Sertraline

Sertraline 400mg/day for 2 weeks, then 200mg/day for 12 weeks, then tapered over 3 weeks.

Trial Locations (2)

Unknown

Infectious Disease Institute, Kampala

Mbarara University of Science and Technology, Mbarara

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Infectious Disease Institute, Kampala, Uganda

OTHER

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Mbarara University of Science and Technology

OTHER

collaborator

Medical Research Council

OTHER_GOV

collaborator

Wellcome Trust

OTHER

collaborator

Makerere University

OTHER

lead

University of Minnesota

OTHER